SCNI
ScinaiยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SCNI Profile
Scinai Immunotherapeutics Ltd.
A biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses
Pharmaceutical
07/22/2003
05/12/2015
NASDAQ Stock Exchange
31
12-31
Depository Receipts (Ordinary Shares)
Jerusalem BioPark
, 2nd floor
, Hadassah Ein Kerem Campus
, Jerusalem
, Israel
--
Scinai Immunotherapeutics Ltd., established in Israel on July 22, 2003, is a private company. The Company is a biopharmaceutical company focused on the development, manufacture and commercialization of innovative inflammation and immunology (I & I) biological products primarily for the treatment of autoimmune and infectious diseases. With advanced biopharmaceutical product development and manufacturing facilities and experienced pharmaceutical industry leadership, Scinai provides end-to-end boutique CDMO services while developing its own diverse and commercially viable pipeline of products and platforms for diseases with a large number of unmet medical needs.
